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doi:10.1Background: Pulmonary artery size is a crucial determinant of hemodynamic energy loss in total cavopulmonary
connections. We investigated the effect of aortic arch reconstruction on left pulmonary artery size based on their
anatomic proximity.
Methods: Thirty-two patients undergoing the Fontan operation, 16 with hypoplastic left heart syndrome and 16
with non–hypoplastic left heart syndrome, were selected from the multicenter Fontan magnetic resonance imag-
ing database at the Georgia Institute of Technology. The 16 datasets were consecutive with full anatomic recon-
structions of the total cavopulmonary connection and aortic arch with no artifacts. The size of the aorta along the
transverse arch and left pulmonary artery size in the region below the aortic arch was quantified by using a pre-
viously validated skeletonization technique.
Results: The transverse aortic and left pulmonary artery measurements (median, maximum, and minimum,
respectively) for non–hypoplastic left heart syndrome were 2.2, 3.1, and 1.5 cm/m and 1.2, 1.6, and 0.2 cm/m,
respectively, compared with 2.5, 4.1, and 2.0 cm/m and 0.9, 1.5, and 0.4 cm/m for patients with hypoplastic
left heart syndrome. Thus the transverse aortic diameter of patients with hypoplastic left heart syndrome was,
on average, 24% greater than that for patients with non–hypoplastic left heart syndrome (P< .05), whereas
the left pulmonary artery diameter of patients with hypoplastic left heart syndrome was smaller than that of
patients with non–hypoplastic left heart syndrome (P< .05). Regression analysis showed a significant negative
correlation (P< .05) between aortic and left pulmonary artery diameters in both the hypoplastic left heart syn-
drome and non–hypoplastic left heart syndrome groups. However, when the study population was regrouped
into reconstructed aorta and nonreconstructed aorta groups, the negative correlation was only significant for
patients with reconstructed aortas, regardless of ventricular pathology (P< .02).
Conclusions: Stage 1 aortic reconstruction procedures that result in a large aorta limit left pulmonary artery size
in patients undergoing the Fontan operation. (J Thorac Cardiovasc Surg 2010;139:557-61)Pulmonary artery stenosis is a common lesion that limits the
efficacy of the Fontan operation,1-3 particularly because
patients with single-ventricle Fontan physiology need an en-
ergy-efficient circulatory system for minimizing the work
load on the single ventricle.4,5 Although there exist several
studies that focus on characterizing the hemodynamics of
various stages leading to Fontan physiology,4-7 there is yet
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The Journal of Thoracic and CaOur previous article8 and that of Senzaki and colleagues9
showed that a limiting pulmonary artery causes significant
energy losses that affect the resting cardiac output or ventric-
ular afterload.
With the large anatomic database of patients undergoing
the Fontan operation available at the Georgia Institute of
Technology, it is now possible to study how various vessels
might interact with one another with respect to their complex
anatomies. The present work focuses on a possible physical
interaction between the left pulmonary artery (LPA) and aor-
tic arch because the 2 structures are intimately close and con-
nected; that is, the aortic arch passes over the LPA, as
depicted in the full anatomic reconstruction shown in
Figure 1. Noticing that the aorta shown in Figure 1 is large
and has been reconstructed during the first stage of the 3
Fontan operations, we hypothesize that stenosis in the
LPA might be caused by the physical constraints placed
on the LPA by the reconstructed aortic geometry. The pres-
ent work tests this hypothesis in 2 distinct classes of patients
with single-ventricle physiology, those with hypoplastic left
heart syndrome (HLHS) and those with non–hypoplastic left
heart syndrome (NHLHS), because aortic reconstruction is
performed in both of these groups. The results of thisrdiovascular Surgery c Volume 139, Number 3 557
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D55Abbreviations and Acronyms8BSA ¼The Jobody surface areaHLHS ¼ hypoplastic left heart syndrome
LPA ¼ left pulmonary artery
MRI ¼ magnetic resonance imaging
NHLHS ¼ non–hypoplastic left heart syndrome
NRA ¼ nonreconstructed aorta
RA ¼ reconstructed aorta
TCPC ¼ total cavopulmonary connectionFIGURE 1. Example of a reconstructed aorta overlaying a narrowed left
pulmonary artery.work demonstrate how the 3 stages of the Fontan operation
and their outcomes are not entirely independent. Specifi-
cally, although the aortic reconstruction might be optimal
at the time of the operation, it could diminish the efficacy
of an operation at a later stage, calling for a more sophisti-
cated planning of the entire course of palliation.
MATERIALS AND METHODS
Thirty-two patients, 16 each with HLHS and NHLHS, were selected from
a magnetic resonance imaging (MRI) database of patients undergoing the Fon-
tan operation (http://fontan.bme.gatech.edu). The database is part of a National
Institutes of Health–funded ongoing study for understanding Fontan hemody-
namics. All patients were imaged either at Children’s Hospital of Philadelphia
or at Emory University/Children’s Healthcare of Atlanta. Informed consent
was obtained from all patients, and all study protocols complied with the in-
stitutional review boards of the participating hospitals and the Georgia Institute
of Technology. The inclusion criteria for this study were (1) availability of ax-
ial MRI images to reconstruct the total cavopulmonary connection (TCPC)
and aortic arch and (2) availability of clinical information necessary to catego-
rize each study group. Anatomic reconstructions with visible artifacts (some
geometries had loss of MRI signal because of the presence of ‘‘clips’’ in
the vessels from surgical intervention) were excluded from the study group.
Clinical details of the studied patient population are provided in Table 1.
Although the Fontan database has more than 200 MRI datasets, this study
was limited to the first 16 HLHS and NHLHS datasets, which proved to
be statistically sufficient. Although each patient has a unique diagnosis
(Table 1), the HLHS/NHLHS status grouping differentiates them with re-
spect to the underlying congenital defect, as done previously.8,10,11 For all
32 patients, the anatomies of the TCPC and aortic arch were reconstructed
by using standard segmentation and reconstruction techniques.12,13 The ef-
fect of the aortic arch on the LPA was quantified by measuring the cross-
sectional areas of the 2 vessels at the closest approach in the arch. The
diameter at the cross-section is defined as the diameter of a circular cross-
section for that area. This was performed by using the skeletonization
method depicted in Figure 2. The skeletonization method has been previ-
ously used to study the geometric characteristics of the TCPC.10
Because the data were nonnormally distributed and corresponded to a 2-
sample population (HLHS vs NHLHS or reconstructed aorta [RA] vs non-
reconstructed aorta [NRA]), the nonparametric Mann–Whitney test was
used to examine statistical significance among the various geometric param-
eters evaluated.
RESULTS
The results consist of statistical analysis of the aortic and
LPA diameter measurements of the 32 patients normalized
by the square root of the patient’s body surface area
(BSA) based on available allometric relationship.14 Theurnal of Thoracic and Cardiovascular Surgdata are analyzed between the HLHS versus NHLHS patient
groups and also simultaneously between the RA versus NRA
groups. We define the RA group as undergoing reconstruction
that involves the aortic arch from the ascending portion to the
ductus insertion region. For instance, a repair of an aortic co-
arctation is not defined as an RA. This is necessary to precisely
determine whether an RA is a factor in LPA narrowing inde-
pendent of underlying ventricular abnormality.
Figure 3 shows a scatter plot of the transverse aortic and
LPA diameters normalized by BSA
1/2
for all the patients.ery c March 2010
TABLE 1. Clinical diagnoses of the 32 patients selected for this study
Patient no. Diagnosis Aorticreconstruction BSA (m2) Age (y)
Patients with HLHS
1 DORV, MA, HLHS Yes 1.22 12
2 HLHS Yes 1.68 14
3 TGA, SLL, LAVV atresia, severe sub-PS with LPA occlusion No 1.30 19
4 HLHS Yes 0.94 8
5 HLHS, ASD, LSVC to CS, clotted RSVC Yes 1.43 17
6 D-transposition, LV hypoplasia, left SVC to coronary sinus Yes 1.9 16
7 HLHS, ASD Yes 1.23 12
8 HLHS Yes 1.358 16
9 HLHS Yes 0.994 10
10 DORV, subaortic VSD, PS, hypoplastic MV and LV Yes 2.05 19
11 LTGA, SLL, DORV, VSD, PS Yes 0.69 9
12 HLHS Yes 0.83 6
13 HLHS Yes 0.963 9
14 HLHS Yes 0.81 5
15 HLHS, bilateral SVC Yes 0.91 7
16 HLHS, ASD Yes 0.83 6
Patients with NHLHS
17 HRHS, Ebstein’s anomaly of tricuspid No 1.02 8
18 TA, VSD No 1.32 10
19 SV with subaortic and aortic valve stenosis Yes 1.045 10
20 TA, pulmonary stenosis, transposition No 1.9 24
21 HRV, TA, TGA, VSD Yes 0.88 8
22 TA, VSD, bilateral SVC No 1.84 20
23 HRV, TA No 0.69 5
24 HRV, TGA, TA, VSD, LPA hypoplasia No 0.58 2
25 TA, VSD No 0.872 7
26 PA, IVS No 1.177 11
27 SV DI–LV, VPS–TGA Yes 1.064 9
28 SV–PA, IVS, HRV No 1.04 12
29 Subpulmonary stenosis, HRV, TGA, VSD Yes 0.813 6
30 TA, D-transposition, hypoplastic arch, small VSD Yes 0.74 7
31 Pulmonary atresia, HRV No 1.49 15
32 Single ventricle–DORV, VSD, aortic arch hypoplasia Yes 1.41 14
BSA, Body surface area; HLHS, hypoplastic left heart syndrome; DORV, double-outlet right ventricle; MA, mitral atresia; TGA, transposition of the great arteries; SLL, situs solitus;
LAVV, left atrioventricular valve; PS, pulmonary stenosis; LPA, left pulmonary artery; ASD, atrial septal defect; LSVC, left superior vena cava; CS, coronary sinus; RSVC, right
superior vena cava; LV, left ventricle; SVC, superior vena cava; NHLHS, non–hypoplastic left heart syndrome VSD, ventricular septal defect; MV, mitral valve; LTGA, levo trans-
position of the great arteries; HRHS, hypoplastic right heart syndrome; TA, tricuspid atresia; SV, single ventricle; HRV, hypoplastic right ventricle; PA, pulmonary atresia; IVS, intact
ventricular septum; DI, double inlet; VPS, valvar pulmonary stenosis.
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DThe figure also compares these data against average values for
healthy children (approximately 1.0 cm/m for the LPA and
1.5 cm/m for the transverse aorta).14 For the NHLHS patient
group the median, maximum, and minimum values for the
aortic and LPA measurements were 2.2, 3.1, and 1.5 cm/m
and 1.2, 1.6, and 0.2 cm/m, respectively. For the HLHS pa-
tient group, these scatter characteristics were 2.5, 4.1, and
2.0 cm/m and 0.9, 1.5, and 0.4 cm/m for the aortic and
LPA measurements, respectively.
The mean of the normalized aortic and LPA diameters are
shown in Figure 4 and are compared statistically. The aortic
diameter for the HLHS patient group was statistically greater
(P< .05) than that for the NHLHS patient group by about
24%. Figure 4 also shows that the LPA diameter for the
HLHS patient group is smaller than that for the NHLHS pa-
tient group (P< .05). Figure 4, B, shows the same compar-The Journal of Thoracic and Caison between aortic and LPA diameters between patients for
the RA versus NRA groups. Aortic diameter is statistically
greater and LPA diameter is statistically smaller in patients
with an RA versus those with an NRA.
Figure 5 depicts results from regression analysis of the
data between the HLHS versus NHLHS and RA versus
NRA groups, respectively, where the LPA diameter is plotted
as a function of the aortic diameter. Figure 5, A, shows that in
both the HLHS and NHLHS groups there is a statistically sig-
nificant (P<.05) association between increasing aortic diam-
eter causing decreasing LPA diameter. Figure 5, B, however
shows that the NRA group does not have any statistically
significant association between increasing aortic diameter
and decreasing LPA diameter. In addition, the P value for
statistical significance for the RA group is the smallest
(P ¼ .012).rdiovascular Surgery c Volume 139, Number 3 559
FIGURE 2. Skeletonization view of the aorta–left pulmonary artery overlap
region. Ribbons are cross-sections of the respective vessels. The minimum left
pulmonary artery area was located, followed by the area of the transverse aor-
tic cross-section closest to the minimum left pulmonary artery location.
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FIGURE 4. Comparison between aortic and left pulmonary artery (LPA)
sizes at the junction across the hypoplastic left heart syndrome (HLHS)
and non–hypoplastic left heart syndrome (NHLHS) patient groups (A)
and patients with reconstructed arteries (RA) and nonreconstructed arteries
(NRA) (B), respectively. *P< .05.
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DDISCUSSION
Figures 1 and 2 clearly depict the possible effect a large
aorta can have on the LPA that is anatomically situated right
below the arch. Note that all of these reconstructions are blood
volumes only; that is, the surfaces in Figures 1 and 2 are the
inner walls of the lumen. Therefore the small gap seen be-
tween the aorta and the LPA in Figure 2 is in fact occupied
by the vessel wall thickness. Examination of the raw MRI im-
ages confirmed this. From Figure 3, notice that almost all the
patients have aortas bigger than that seen in a healthy child,14
whereas the LPA is distributed equally about the normal rangeD
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FIGURE 3. Scatter plot of measured transverse aortic and left pulmonary
artery (LPA) diameters for the non–hypoplastic left heart syndrome
(NHLHS) and hypoplastic left heart syndrome (HLHS) patient groups.
The solid and dashed lines represent normal LPA and transverse aortic di-
mensions, respectively, in healthy children. BSA, Body surface area.
560 The Journal of Thoracic and Cardiovascular Surgfor patients with HLHS and skewed in patients with NHLHS.
To give a feel for the range of aortic sizes, the smallest aorta in
the entire dataset was the most normal (ie, healthy), with a size
of 1.5 cm/m (the same as for healthy patients14), whereas the
largest aorta was 2.7 times bigger at 4.1 cm/m. This implies
that this enlarged aorta provides 7.5 times more flow area.
The maximum aortic size was 3.7 cm (patient BSA was
0.83 m2), and the patient would have 225% more flow area
when an adult (based on an adult aorta of 2.5 cm). An en-
larged aorta of such proportions itself creates significant en-
ergy losses because of the expansion and contraction of the
aortic flow, thus further increasing the energetic load on the
single ventricle. The smallest LPA was 0.2 cm/m, which pro-
vides roughly 25 times lower flow area than in a healthy LPA.
The scatter of LPA in the NHLHS group shows that there was
1 patient with an abnormally low LPA value, whereas the rest
were skewed above the normal healthy value. For the HLHS
group, the LPA scatter was about equally distributed about the
healthy/normal value.
Statistical analysis represented in Figure 4 clearly shows
that the aortic diameter was larger for the HLHS groupery c March 2010
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FIGURE 5. Indexed left pulmonary artery (LPA) diameter plotted against
indexed aortic diameter at the junction, with regression analysis shown for
the hypoplastic left heart syndrome (HLHS) and non–hypoplastic left heart
syndrome (NHLHS) patient groups (A) and patients with reconstructed
arteries (RA) and nonreconstructed arteries (NRA) (B), respectively.
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Analysis also showed that the aortic diameter was larger in
the RA group compared with that seen in the NRA group
(P < .01). This might be explained because the dataset
also showed it is more probable that a patient with HLHS
has an RA, with a probability of 93.75%. In stark compari-
son, the probability that a patient with NHLHS has an RA is
only 37.50%. Therefore the statistical significance for the
larger aorta in Figure 4, A, is due to the confounding variable
of whether the aorta was reconstructed.
However, this still leaves the question of whether an en-
larged aorta constricts the LPA. To answer this question,
we performed regression analysis, as depicted in Figure 5.
Figure 5, A, shows that in both the HLHS and NHLHS
groups, increased aortic size resulted in decreased LPA
size. However, as shown in Figure 5, B, increased aortic
size resulted in a statistically significant reduction in LPA
size only for the RA patient group (P ¼ .012). Moreover,
for the NRA group, there was no statistically significant cor-
relation, with a high P value of .37. This implies that narrow-
ing of the LPA is only related to RAs and the underlying
defect (HLHS or NHLHS) does not play a role.
Although this study shows how important stage 1 recon-
struction can be in the development of LPA in patients un-
dergoing the Fontan operation, it also brings to attention
the following question: What is a good aortic reconstruction
size? Although this study does not provide a direct answer,
we do want to mention that enlarged aortas, such as those
discussed above, with a cross-sectional area more than twice
the size of a typical adult transverse aorta will contribute to
increased hemodynamic energy loss. Given that, we recom-
mend that the RA be no larger than a healthy adult aorta. An
additional parameter that can mitigate the constriction of the
LPA by the aorta is the length of the aortic arch. A longerThe Journal of Thoracic and Calength would force the arch to shift in the superior direction,
thus relatively moving away from the LPA.CONCLUSION AND SIGNIFICANCE
It has been shown that aortic reconstruction that takes
place in stage 1 of the 3 palliative surgical procedures that
result in Fontan physiology plays a crucial role in LPA
growth. Specifically, an enlarged aorta might contribute to
diminished LPA size, possibly because of imposed spatial
constraints. RAs with more than twice the flow area of an
adult aorta were noted in these young patients, and this dem-
onstrates that there needs to be an upper limit placed on the
allowable size of an RA in pediatric patients. An enlarged
aorta might not only cause LPA stenosis but also in itself cre-
ate significant energy losses because of the expansion and
contraction of the flow, thus further increasing the energetic
load on the single ventricle.References
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